How The Trump Administration Will Impact The Future of Clinical Trials and Biopharma
The re-election of Donald Trump in 2024 marks the start of a dramatic transformation in healthcare, biotech, and clinical...
The re-election of Donald Trump in 2024 marks the start of a dramatic transformation in healthcare, biotech, and clinical...
In a conversation with Dr. Stephanie Manson Brown, Head of Clinical Development at Allergan Aesthetics, we explore the company’s initiatives to...
At the SCOPE EU conference, Julius Kusserow, an R&D Standards Expert at Bayer AG, presented a transformative vision for...
In this interview, we speak with Rajesh Devraj, Ph.D., President & CEO and Pol Boudes, M.D., Chief Medical Officer...
In this interview, we speak with Tim Smith, co-founder and CTO at Medable, to discuss AI’s role in addressing...
The 2024 SCOPE Europe conference featured a presentation on clinical trial diversity, highlighting the critical need for diversity and...
In this discussion, Moe Alsumidaie interviews Peter Schiemann, CEO and Chairman of Ymmunobio, about the company’s innovative approaches to...
At SCOPE Summit Europe 2024, industry leaders gathered to explore the transformative potential of patient perspectives in decentralized clinical...
In this insightful discussion, we interview Anthony Caggiano, Chief Medical Officer and Lisa Ricciardi, CEO, of Cognition Therapeutics about...
In this interview, we speak with Dr. Kuldip Dave from the ALS Association to explore their strategic approach to...